CN Patent

CN105801568B — 阿法替尼一马来酸盐晶型及其制备方法和药物组合物

Assigned to Ni Yun · Expires 2019-07-30 · 7y expired

What this patent protects

本发明涉及新型的阿法替尼一马来酸盐晶型及其制备方法。与已知的阿法替尼盐晶型相比，本发明的阿法替尼一马来酸盐晶型具有多种改进的特性。本发明还涉及包含所述阿法替尼一马来酸盐晶型的药物组合物，以及在制备用于治疗晚期非小细胞肺癌(NSCLC)及HER2阳性的晚期乳腺癌的药物中的用途。

USPTO Abstract

本发明涉及新型的阿法替尼一马来酸盐晶型及其制备方法。与已知的阿法替尼盐晶型相比，本发明的阿法替尼一马来酸盐晶型具有多种改进的特性。本发明还涉及包含所述阿法替尼一马来酸盐晶型的药物组合物，以及在制备用于治疗晚期非小细胞肺癌(NSCLC)及HER2阳性的晚期乳腺癌的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105801568B
Jurisdiction
CN
Classification
—
Expires
2019-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Ni Yun
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.